U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 149

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr1:187113113-224487119
GRCh38:
Chr1:187143981-224299417
ADIPOR1, ADORA1, AIDA, ANGEL2, ARL8A, ASCL5, ASPM, ATF3, ATP2B4, ATP6V1G3, AVPR1B, B3GALT2, BATF3, BLACAT1, BMNCR, BPNT1, BRINP3, BRINP3-DT, BROX, BTG2, BTG2-DT, C1orf115, C1orf116, C1orf53, C1orf74, C4BPA, C4BPB, CACNA1S, CAMK1G, CAMSAP2, CAPN2, CAPN8, CCDC185, CD34, CD46, CD55, CDC73, CDK18, CENPF, CFH, CFHR1, CFHR2, CFHR3, CFHR4, CFHR5, CHI3L1, CHIT1, CNTN2, CR1, CR1L, CR2, CRB1, CSRP1, CSRP1-AS1, CTSE, CYB5R1, DDX59, DDX59-AS1, DEGS1, DENND1B, DISP1, DSTYK, DTL, DUSP10, DYRK3, DYRK3-AS1, EIF2D, ELF3, ELF3-AS1, ELK4, EPRS1, ERLNC1, ESRRG, ETNK2, F13B, FAM177B, FAM72A, FBXO28, FCAMR, FCMR, FLVCR1, FLVCR1-DT, FMOD, G0S2, GARIN4, GLRX2, GOLT1A, GPATCH2, GPR25, GPR37L1, HHAT, HHIPL2, HLX, HLX-AS1, HSD11B1, HSD11B1-AS1, IARS2, IGFN1, IKBKE, IKBKE-AS1, IL10, IL19, IL20, IL24, INAVA, INTS7, IPO9, IPO9-AS1, IRF6, KCNH1, KCNH1-IT1, KCNK2, KCNT2, KCTD3, KDM5B, KIF14, KIF21B, KISS1, KLHDC8A, KLHL12, LAD1, LAMB3, LAX1, LEMD1, LEMD1-AS1, LEMD1-DT, LGR6, LHX9, LINC00210, LINC00260, LINC00303, LINC00467, LINC00538, LINC00628, LINC00862, LINC01031, LINC01035, LINC01036, LINC01037, LINC01221, LINC01222, LINC01352, LINC01353, LINC01653, LINC01655, LINC01680, LINC01696, LINC01698, LINC01710, LINC01717, LINC01720, LINC01724, LINC01740, LINC01774, LINC02257, LINC02474, LINC02602, LINC02608, LINC02767, LINC02769, LINC02771, LINC02773, LINC02779, LINC02789, LINC02817, LINC02869, LMOD1, LOC101927143, LOC101927164, LOC103021295, LOC107325941, LOC107325942, LOC107548112, LOC107988045, LOC108281163, LOC108281185, LOC110120610, LOC110120807, LOC110121042, LOC110121056, LOC110121057, LOC110121081, LOC110121257, LOC110121306, LOC111365207, LOC111429603, LOC111429604, LOC111429612, LOC111556116, LOC111721704, LOC112577523, LOC112577526, LOC112577527, LOC112577528, LOC112577529, LOC112577530, LOC112577531, LOC112577532, LOC112577533, LOC112577534, LOC112577535, LOC112577536, LOC112577537, LOC112577538, LOC112577542, LOC112577543, LOC113939983, LOC113939984, LOC114827844, LOC115804237, LOC115804238, LOC115804239, LOC115804240, LOC115804242, LOC115804243, LOC115804244, LOC115804245, LOC115804246, LOC120807609, LOC120807610, LOC120893169, LOC120893170, LOC120893171, LOC120893172, LOC120893173, LOC120893174, LOC120893175, LOC120893176, LOC120908903, LOC120908904, LOC120908905, LOC120908906, LOC120908907, LOC120908908, LOC120908909, LOC120908910, LOC121725067, LOC121725068, LOC121725069, LOC121725070, LOC121725071, LOC121725072, LOC121725073, LOC121725074, LOC122094914, LOC122128411, LOC122149331, LOC122149332, LOC122149333, LOC122149334, LOC122149335, LOC122149336, LOC122149337, LOC122149338, LOC122149339, LOC122149340, LOC122149341, LOC122149342, LOC122149343, LOC122149344, LOC122149345, LOC122149346, LOC122149347, LOC122149348, LOC122149349, LOC122149350, LOC122149351, LOC122149352, LOC122149353, LOC122149354, LOC122149355, LOC122149356, LOC122149357, LOC122149358, LOC122149359, LOC122149360, LOC122149361, LOC122149362, LOC122149487, LOC122149488, LOC122149489, LOC122149490, LOC122149491, LOC122149492, LOC122149493, LOC122149494, LOC122149495, LOC122149496, LOC122149497, LOC122152293, LOC122152294, LOC122152295, LOC122152296, LOC122152297, LOC122152298, LOC122152299, LOC122152300, LOC122152301, LOC122152302, LOC122152303, LOC122152304, LOC122152305, LOC122152306, LOC122152307, LOC122152308, LOC124904584, LOC148696, LOC284581, LPGAT1, LPGAT1-AS1, LRRN2, LYPLAL1, LYPLAL1-AS1, LYPLAL1-DT, MAPKAPK2, MARK1, MDM4, MFSD4A, MFSD4A-AS1, MIA3, MIR1231, MIR1278, MIR135B, MIR181A1, MIR181A1HG, MIR181B1, MIR194-1, MIR205, MIR205HG, MIR215, MIR29B2, MIR29B2CHG, MIR29C, MIR3122, MIR320B2, MIR4260, MIR4426, MIR4735, MIR5191, MIR664A, MIR6739, MIR6740, MIR6769B, MTARC1, MTARC2, MYBPH, MYOG, MYOPARR, NAV1, NEK2, NEK2-DT, NEK7, NENF, NFASC, NR5A2, NSL1, NTRAS, NUAK2, NUCKS1, NVL, OPTC, PACC1, PCAT6, PFKFB2, PHLDA3, PIGR, PIK3C2B, PKP1, PLEKHA6, PLXNA2, PM20D1, PPFIA4, PPP1R12B, PPP1R15B, PPP2R5A, PRELP, PROX1, PROX1-AS1, PTPN14, PTPN7, PTPRC, RAB29, RAB3GAP2, RAB7B, RABIF, RASSF5, RBBP5, RCOR3, RD3, REN, RGS1, RGS13, RGS18, RGS2, RGS2-AS1, RGS21, RHEX, RNPEP, RO60, RPS6KC1, RRP15, SCARNA18B, SERTAD4, SERTAD4-AS1, SHISA4, SLC26A9, SLC26A9-AS1, SLC30A1, SLC30A10, SLC41A1, SLC45A3, SMYD2, SNORA16B, SNORA36B, SNORA70H, SNORA77, SNRPE, SOX13, SPATA17, SPATA17-AS1, SPATA45, SRGAP2, SUSD4, SYT14, SYT2, TAF1A, TAF1A-AS1, TATDN3, TGFB2, TGFB2-AS1, TGFB2-OT1, TIMM17A, TLR5, TMCC2, TMCC2-AS1, TMEM183A, TMEM81, TMEM9, TNNI1, TNNT2, TP53BP2, TRAF3IP3, TRAF5, TRK-TTT3-1, TRK-TTT3-2, TRK-TTT8-1, TRT-TGT2-1, UBE2T, UCHL5, USH2A, USH2A-AS1, USH2A-AS2, UTP25, VASH2, YOD1, ZBED6, ZBTB41, ZC3H11A, ZC3H11B, ZNF281
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
2.
GRCh38:
Chr1:204033173-208209798
AutismLikely pathogenic
(Mar 20, 2018)
criteria provided, single submitter
3.
GRCh37:
Chr1:204124145
GRCh38:
Chr1:204155017
RENnot providedUncertain significance
(Apr 22, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr1:204124149
GRCh38:
Chr1:204155021
RENR406CHepatoblastomaLikely pathogenicno assertion criteria provided
5.
GRCh37:
Chr1:204124169
GRCh38:
Chr1:204155041
RENR399Hnot providedUncertain significance
(Dec 8, 2021)
criteria provided, single submitter
6.
GRCh37:
Chr1:204124178
GRCh38:
Chr1:204155050
RENR396HInborn genetic diseasesLikely benign
(Dec 21, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr1:204124179
GRCh38:
Chr1:204155051
RENR396CFamilial juvenile hyperuricemic nephropathy type 2Uncertain significancecriteria provided, single submitter
8.
GRCh37:
Chr1:204124182
GRCh38:
Chr1:204155054
RENnot providedLikely benign
(May 3, 2018)
criteria provided, single submitter
9.
GRCh37:
Chr1:204124205
GRCh38:
Chr1:204155077
RENR387Qnot provided, Familial juvenile hyperuricemic nephropathy type 2Uncertain significance
(Nov 29, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr1:204124206
GRCh38:
Chr1:204155078
RENR387*Hyperproreninemia, familialPathogenic
(Dec 2, 1994)
no assertion criteria provided
11.
GRCh37:
Chr1:204124247
GRCh38:
Chr1:204155119
RENP373LFamilial juvenile hyperuricemic nephropathy type 2, Renal tubular dysgenesisConflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
12.
GRCh37:
Chr1:204124264
GRCh38:
Chr1:204155136
RENnot providedLikely benign
(Jan 23, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr1:204124289
GRCh38:
Chr1:204155161
RENK359IRenal tubular dysgenesis, Familial juvenile hyperuricemic nephropathy type 2Conflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
14.
GRCh37:
Chr1:204124371
GRCh38:
Chr1:204155243
RENnot providedBenign
(May 15, 2021)
criteria provided, single submitter
15.
GRCh37:
Chr1:204124545
GRCh38:
Chr1:204155417
RENnot providedBenign
(Jun 21, 2021)
criteria provided, single submitter
16.
GRCh37:
Chr1:204124865
GRCh38:
Chr1:204155737
RENnot providedBenign
(May 14, 2021)
criteria provided, single submitter
17.
GRCh37:
Chr1:204124975
GRCh38:
Chr1:204155847
RENFamilial juvenile hyperuricemic nephropathy type 2, Renal tubular dysgenesisConflicting interpretations of pathogenicity
(Jan 22, 2018)
criteria provided, conflicting interpretations
18.
GRCh37:
Chr1:204124976
GRCh38:
Chr1:204155848
RENT344Mnot provided, Inborn genetic diseasesUncertain significance
(Oct 3, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr1:204124998
GRCh38:
Chr1:204155870
RENH337Ynot providedBenign
(Jul 5, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr1:204125029
GRCh38:
Chr1:204155901
RENnot providedLikely benign
(Mar 28, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr1:204125038
GRCh38:
Chr1:204155910
RENnot providedLikely benign
(Dec 4, 2017)
criteria provided, single submitter
22.
GRCh37:
Chr1:204125051
GRCh38:
Chr1:204155923
RENRenal tubular dysgenesis, not provided, Familial juvenile hyperuricemic nephropathy type 2
Conflicting interpretations of pathogenicity
(Jan 23, 2022)
criteria provided, conflicting interpretations
23.
GRCh37:
Chr1:204125054
GRCh38:
Chr1:204155926
RENnot providedLikely benign
(Jan 28, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr1:204125058
GRCh38:
Chr1:204155930
RENFamilial juvenile hyperuricemic nephropathy type 2, Renal tubular dysgenesisUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
25.
GRCh37:
Chr1:204125089
GRCh38:
Chr1:204155961
RENnot providedBenign
(May 15, 2021)
criteria provided, single submitter
26.
GRCh37:
Chr1:204125272
GRCh38:
Chr1:204156144
RENnot providedBenign
(May 14, 2021)
criteria provided, single submitter
27.
GRCh37:
Chr1:204125312
GRCh38:
Chr1:204156184
RENnot providedBenign
(Sep 27, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr1:204125337
GRCh38:
Chr1:204156209
RENE310GInborn genetic diseasesUncertain significance
(Aug 3, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr1:204125338
GRCh38:
Chr1:204156210
RENE310Knot providedUncertain significance
(Jul 20, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr1:204125352
GRCh38:
Chr1:204156224
RENI305TInborn genetic diseasesUncertain significance
(Jul 8, 2021)
criteria provided, single submitter
31.
GRCh37:
Chr1:204125395
GRCh38:
Chr1:204156267
RENV291IFamilial juvenile hyperuricemic nephropathy type 2, Renal tubular dysgenesisUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
32.
GRCh37:
Chr1:204125411
GRCh38:
Chr1:204156283
RENRenal tubular dysgenesis, Familial juvenile hyperuricemic nephropathy type 2Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
33.
GRCh37:
Chr1:204125434
GRCh38:
Chr1:204156306
RENS278PFamilial juvenile hyperuricemic nephropathy type 2, Renal tubular dysgenesisUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
34.
GRCh37:
Chr1:204125457
GRCh38:
Chr1:204156329
RENnot providedBenign
(Oct 19, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr1:204125464-204125465
GRCh38:
Chr1:204156336-204156337
RENnot providedUncertain significance
(Jul 23, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr1:204125464-204125465
GRCh38:
Chr1:204156336-204156337
RENRenal tubular dysgenesis of genetic origin, Familial juvenile hyperuricemic nephropathy type 2, not provided
Benign/Likely benign
(Oct 23, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr1:204125464-204125465
GRCh38:
Chr1:204156336-204156337
RENnot providedBenign
(Oct 17, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr1:204125464-204125465
GRCh38:
Chr1:204156336-204156337
RENnot providedBenign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr1:204125464-204125465
GRCh38:
Chr1:204156336-204156337
RENnot providedBenign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr1:204125465-204125472
GRCh38:
Chr1:204156337-204156344
RENnot providedUncertain significance
(Sep 15, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr1:204125465-204125468
GRCh38:
Chr1:204156337-204156340
RENnot providedBenign
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr1:204125509
GRCh38:
Chr1:204156381
RENnot providedBenign
(May 15, 2021)
criteria provided, single submitter
43.
GRCh37:
Chr1:204125806
GRCh38:
Chr1:204156678
RENG273Rnot provided, Renal tubular dysgenesis, Familial juvenile hyperuricemic nephropathy type 2
Uncertain significance
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr1:204125813
GRCh38:
Chr1:204156685
RENnot providedLikely benign
(Apr 4, 2018)
criteria provided, single submitter
45.
GRCh37:
Chr1:204125866
GRCh38:
Chr1:204156738
RENE253KInborn genetic diseasesUncertain significance
(Jan 19, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr1:204125879
GRCh38:
Chr1:204156751
REND248Enot provided, Renal tubular dysgenesis, Familial juvenile hyperuricemic nephropathy type 2
Conflicting interpretations of pathogenicity
(Sep 12, 2022)
criteria provided, conflicting interpretations
47.
GRCh37:
Chr1:204125905
GRCh38:
Chr1:204156777
RENG240RRenal tubular dysgenesis, Renal tubular dysgenesis of genetic origin, Familial juvenile hyperuricemic nephropathy type 2,
Familial juvenile hyperuricemic nephropathy type 2
Uncertain significance
(Mar 18, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr1:204125912
GRCh38:
Chr1:204156784
RENnot providedLikely benign
(Aug 8, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr1:204125930
GRCh38:
Chr1:204156802
RENnot providedLikely benign
(Aug 23, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr1:204125936
GRCh38:
Chr1:204156808
RENnot providedLikely benign
(Oct 10, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr1:204125987
GRCh38:
Chr1:204156859
RENnot providedBenign
(May 15, 2021)
criteria provided, single submitter
52.
GRCh37:
Chr1:204126378
GRCh38:
Chr1:204157250
RENnot providedBenign
(May 15, 2021)
criteria provided, single submitter
53.
GRCh37:
Chr1:204128273
GRCh38:
Chr1:204159145
RENnot providedBenign
(Jun 21, 2021)
criteria provided, single submitter
54.
GRCh37:
Chr1:204128527
GRCh38:
Chr1:204159399
RENR230KRenal tubular dysgenesisPathogenic
(Sep 1, 2005)
no assertion criteria provided
55.
GRCh37:
Chr1:204128553
GRCh38:
Chr1:204159425
RENnot provided, Renal tubular dysgenesis, Familial juvenile hyperuricemic nephropathy type 2
Conflicting interpretations of pathogenicity
(Jul 12, 2022)
criteria provided, conflicting interpretations
56.
GRCh37:
Chr1:204128555
GRCh38:
Chr1:204159427
RENE221KRenal tubular dysgenesis, Familial juvenile hyperuricemic nephropathy type 2Uncertain significance
(Mar 16, 2018)
criteria provided, single submitter
57.
GRCh37:
Chr1:204128567
GRCh38:
Chr1:204159439
RENG217Rnot provided, Familial juvenile hyperuricemic nephropathy type 2, Renal tubular dysgenesis,
Kidney disorder
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr1:204128585
GRCh38:
Chr1:204159457
REND211NInborn genetic diseasesUncertain significance
(Sep 14, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr1:204128586
GRCh38:
Chr1:204159458
RENnot provided, Familial juvenile hyperuricemic nephropathy type 2, Renal tubular dysgenesis
Conflicting interpretations of pathogenicity
(Jun 5, 2018)
criteria provided, conflicting interpretations
60.
GRCh37:
Chr1:204128602
GRCh38:
Chr1:204159474
RENR205KKidney disorderUncertain significance
(Jun 25, 2018)
criteria provided, single submitter
61.
GRCh37:
Chr1:204128673
GRCh38:
Chr1:204159545
RENnot providedLikely benign
(Feb 18, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr1:204128683
GRCh38:
Chr1:204159555
RENT178Mnot provided, Familial juvenile hyperuricemic nephropathy type 2, Renal tubular dysgenesis of genetic origin
Uncertain significance
(Jul 5, 2022)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr1:204128712
GRCh38:
Chr1:204159584
RENnot providedLikely benign
(Dec 27, 2021)
criteria provided, single submitter
64.
GRCh37:
Chr1:204128854
GRCh38:
Chr1:204159726
RENnot providedBenign
(Nov 12, 2018)
criteria provided, single submitter
65.
GRCh37:
Chr1:204129554
GRCh38:
Chr1:204160426
RENnot providedBenign
(May 15, 2021)
criteria provided, single submitter
66.
GRCh37:
Chr1:204129671
GRCh38:
Chr1:204160543
RENKidney disorder, Renal tubular dysgenesis, not specified,
not provided, Familial juvenile hyperuricemic nephropathy type 2
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr1:204129676
GRCh38:
Chr1:204160548
RENnot provided, Renal tubular dysgenesis, Familial juvenile hyperuricemic nephropathy type 2
Conflicting interpretations of pathogenicity
(Oct 3, 2022)
criteria provided, conflicting interpretations
68.
GRCh37:
Chr1:204129682
GRCh38:
Chr1:204160554
RENKidney disorderUncertain significance
(Aug 14, 2018)
criteria provided, single submitter
69.
GRCh37:
Chr1:204129685
GRCh38:
Chr1:204160557
RENnot provided, Renal tubular dysgenesis, Familial juvenile hyperuricemic nephropathy type 2,
Renal tubular dysgenesis of genetic origin, Familial juvenile hyperuricemic nephropathy type 2, Kidney disorder
Benign/Likely benign
(Sep 28, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr1:204129701
GRCh38:
Chr1:204160573
RENQ160RInborn genetic diseasesUncertain significance
(Oct 3, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr1:204129717
GRCh38:
Chr1:204160589
RENS155Gnot providedUncertain significance
(Sep 1, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr1:204129728
GRCh38:
Chr1:204160600
RENT151Knot providedUncertain significance
(Aug 9, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr1:204129737
GRCh38:
Chr1:204160609
RENR148Hnot provided, Kidney disorderUncertain significance
(Jul 27, 2022)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr1:204129738
GRCh38:
Chr1:204160610
RENR148Cnot providedUncertain significance
(Oct 5, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr1:204129758
GRCh38:
Chr1:204160630
RENN141Snot providedUncertain significance
(Aug 5, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr1:204129776
GRCh38:
Chr1:204160648
RENS135YRenal tubular dysgenesisPathogenic
(Jan 15, 2011)
no assertion criteria provided
77.
GRCh37:
Chr1:204129782
GRCh38:
Chr1:204160654
RENS133LFamilial juvenile hyperuricemic nephropathy type 2, Renal tubular dysgenesisConflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
78.
GRCh37:
Chr1:204129790
GRCh38:
Chr1:204160662
RENnot provided, Familial juvenile hyperuricemic nephropathy type 2, Renal tubular dysgenesis
Conflicting interpretations of pathogenicity
(Dec 31, 2019)
criteria provided, conflicting interpretations
79.
GRCh37:
Chr1:204129819
GRCh38:
Chr1:204160691
RENFamilial juvenile hyperuricemic nephropathy type 2, Renal tubular dysgenesisConflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
80.
GRCh37:
Chr1:204130127
GRCh38:
Chr1:204160999
RENnot providedBenign
(Jun 21, 2021)
criteria provided, single submitter
81.
GRCh37:
Chr1:204130217-204130218
GRCh38:
Chr1:204161089-204161090
RENnot providedBenign
(May 15, 2021)
criteria provided, single submitter
82.
GRCh37:
Chr1:204130376
GRCh38:
Chr1:204161248
RENnot provided, Renal tubular dysgenesis, Familial juvenile hyperuricemic nephropathy type 2
Benign
(Nov 7, 2021)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr1:204130413
GRCh38:
Chr1:204161285
RENnot providedLikely benign
(Apr 7, 2018)
criteria provided, single submitter
84.
GRCh37:
Chr1:204130437
GRCh38:
Chr1:204161309
RENR119HInborn genetic diseases, not providedUncertain significance
(Sep 18, 2022)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr1:204130438
GRCh38:
Chr1:204161310
RENR119CInborn genetic diseases, not providedUncertain significance
(Jun 28, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr1:204130471
GRCh38:
Chr1:204161343
RENS108AInborn genetic diseasesLikely benign
(Jan 4, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr1:204130473
GRCh38:
Chr1:204161345
RENS107Lnot providedUncertain significance
(Sep 16, 2018)
no assertion criteria provided
88.
GRCh37:
Chr1:204130476
GRCh38:
Chr1:204161348
RENG106ARenal tubular dysgenesis, Familial juvenile hyperuricemic nephropathy type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
89.
GRCh37:
Chr1:204130493-204130494
GRCh38:
Chr1:204161365-204161366
RENK100fsRenal tubular dysgenesisPathogenic
(Apr 29, 2021)
no assertion criteria provided
90.
GRCh37:
Chr1:204130517
GRCh38:
Chr1:204161389
RENnot providedLikely benign
(Aug 19, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr1:204130526
GRCh38:
Chr1:204161398
RENE89DFamilial juvenile hyperuricemic nephropathy type 2, Renal tubular dysgenesis, Renal tubular dysgenesis of genetic origin,
Familial juvenile hyperuricemic nephropathy type 2
Uncertain significance
(Mar 25, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr1:204130528
GRCh38:
Chr1:204161400
RENE89Knot providedUncertain significance
(Apr 17, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr1:204130529
GRCh38:
Chr1:204161401
RENnot providedLikely benign
(Jun 3, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr1:204130531
GRCh38:
Chr1:204161403
RENG88Snot providedUncertain significance
(May 5, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr1:204130536
GRCh38:
Chr1:204161408
RENY86Cnot providedUncertain significance
(Sep 28, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr1:204130538
GRCh38:
Chr1:204161410
RENQ85HRenal tubular dysgenesisUncertain significance
(Jan 1, 2016)
criteria provided, single submitter
97.
GRCh37:
Chr1:204130542
GRCh38:
Chr1:204161414
RENT84Nnot providedUncertain significance
(Feb 3, 2022)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr1:204130562
GRCh38:
Chr1:204161434
RENnot providedLikely benign
(Sep 23, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr1:204131031
GRCh38:
Chr1:204161903
RENnot providedBenign
(May 15, 2021)
criteria provided, single submitter
100.
GRCh37:
Chr1:204131061-204131062
GRCh38:
Chr1:204161933-204161934
RENnot providedBenign
(May 14, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination